Statins for preventing colorectal adenoma and carcinoma

  • Protocol
  • Intervention

Authors

  • Dipika Bansal,

    Corresponding author
    1. National Institute of Pharmaceutical Education and Research (NIPER), Clinical Research Unit, Department of Pharmacy Practice, Mohali, Punjab, India
    • Dipika Bansal, Clinical Research Unit, Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), F-307, Research Block, NIPER, Sector 67, Mohali, Punjab, 160062, India. dipikabansal079@gmail.com. dipikabansal@niper.ac.in.

    Search for more papers by this author
  • Kapil Gudala,

    1. National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmacy Practice, Mohali, Punjab, India
    Search for more papers by this author
  • Krishna Undela

    1. JSS College of Pharmacy, JSS University, Department of Pharmacy Practice, Mysore, Karnataka, India
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objectives are to assess the effect of statins on the incidence of colorectal adenomatous polyps and on the incidence of CRC compared with placebo. A secondary objective is to evaluate the incidence of adverse effects resulting from this intervention.